E. Daci

发表

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study

L. V. Van Gaal, K. Denhaerynck, I. Abraham, 2019, Diabetes Therapy.

Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data

C. Mathieu, J. Hoste, E. Daci, 2014, Acta clinica Belgica.

Increased Bone Formation in Mice Lacking Plasminogen Activators

R. Bouillon, G. Carmeliet, V. Everts, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).

L. V. Van Gaal, K. Denhaerynck, I. Abraham, 2016, Primary care diabetes.

Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1.

R. Bouillon, G. Carmeliet, A. Verstuyf, 2000, Bone.

Disorders of calcium homeostasis.

R. Bouillon, G. Carmeliet, C. Maes, 2003, Best practice & research. Clinical endocrinology & metabolism.

Vitamin D Metabolism and Action

R. Bouillon, G. Carmeliet, S. Segaert, 1998, Osteoporosis International.

Mice Lacking the Plasminogen Activator Inhibitor 1 Are Protected from Trabecular Bone Loss Induced by Estrogen Deficiency

R. Bouillon, G. Carmeliet, A. Verstuyf, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Role of Plasminogen in Bone Remodeling

T. Martin, E. Daci, E. Allan, 2003 .

Plasminogen activators are involved in the degradation of bone by osteoclasts.

G. Carmeliet, V. Everts, W. Tigchelaar-Gutter, 2008, Bone.

Mechanisms Influencing Bone Metabolism in Chronic Illness

R. Bouillon, E. Daci, S. Van Cromphaut, 2002, Hormone Research in Paediatrics.

Pituitary tumours and bone

R. Bouillon, G. Carmeliet, S. Webb, 1998 .

Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair.

Geert Carmeliet, Peter Carmeliet, A. Luttun, 2006, The Journal of clinical investigation.

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

A. Luttun, P. Carmeliet, H. Dvorak, 2002, Nature Medicine.

The Role of the Plasminogen System in Bone Resorption In Vitro

R. Bouillon, G. Carmeliet, N. Udagawa, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

P. Geusens, S. Boonen, J. Devogelaer, 2013, Calcified Tissue International.

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

P. Geusens, S. Boonen, J. Devogelaer, 2013, Calcified Tissue International.

Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study)

K. Denhaerynck, I. Abraham, C. Hermans, 2013, Annals of dermatology.